A near-autonomous AI chemist powered by GPT-5.4 improved a challenging drug-making reaction in collaboration with Molecule.one. The system autonomously iterated on chemical processes to enhance yields. This integration of LLMs into laboratory workflows reduces manual trial-and-error. It demonstrates a practical path toward fully automated molecular discovery for medicinal chemists.